This browser is no longer supported at MarketWatch. If you’ve got money invested in the market – and especially in popular tech stocks – this is critical information for the days ahead…document.write(''); Fortunes will be made and lost in 2021 – and you likely have just weeks to decide which side you’ll be on. 7/12/2019. The stock … AbbVie () - Get Report shares rose in Thursday trading after the drugmaker's stock was upgraded to buy from neutral at UBS. Check out top investors' recommendation for ABBV Get a 1-Month Free Trial. 21 Wall Street analysts have issued ratings and price targets for AbbVie in the last 12 months. ABBV: AbbVie Inc. broker recommendations. It represents the price at which the analyst would exit his or her existing position. We conduct extensive research on individual companies such as AbbVie and provide practical buy, sell, or hold … Lightning fast & can cost as Little as 5¢ or even 1¢... Start Your Risk-Free Trial Subscription Here, 3 Reliable Dividend Stocks to Buy in January, It Is Almost Time To Buy More Chewy.com (NYSE:CHWY), FAT Brands (NASDAQ: FAT) Stock is a Compelling Bargain Buy, Former head of China state asset firm sentenced to death, Harley Davidson (NYSE: HOG) Stock Giving Pullback Entries Here, NYSE withdraws plans to delist 3 Chinese phone carriers, South Korean tanker was boarded by armed Iran Guard forces, Simply Good Foods (NYSE:SMPL) Is a Simple Bet On Resolutions, Forward Air Stock: A Lesser-Known Way to Play the Transportation Rebound. Learn More AbbVie went public priced at an adjusted price 1 of $24.89 on Jan 2013. 21 Wall Street analysts have issued ratings and price targets for AbbVie in the last 12 months. Today it was reported that the Senior Vice-President Operations of AbbVie (ABBV – Research Report), Jeffrey Ryan Stewart, exercised options to sell 25,290 ABBV shares for a total transaction value of $2.66M.See today’s analyst top recommended stocks >> Based on AbbVie’s latest earnings report for the quarter ending September 30, the company posted quarterly revenue of $12.9 … 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). Learn everything you need to know about successful options trading with this three-part video course. Looking for new stock ideas? MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. According to 16 Wall Street analysts that have issued a 1 year ABBV price target, the average ABBV price target is $114.38, with the highest ABBV stock price forecast at $135.00 and the lowest ABBV stock price forecast at $96.00. ABBV: AbbVie Inc. broker recommendation chart. , and has now gained 5 days in a row. Company Profile. Is The Coca-Cola Company (NYSE:KO) Losing Its Fizz? Today, you can download 7 Best Stocks for the Next 30 Days. Out of 18 analysts, 12 (66.67%) are recommending ABBV as a Strong Buy, 1 (5.56%) are recommending ABBV as a Buy, 5 (27.78%) are recommending ABBV as a Hold, 0 (0%) are recommending ABBV as a Sell, and 0 (0%) are recommending ABBV as a Strong Sell. ABBV: AbbVie Inc. broker recommendation chart. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Get daily stock ideas top-performing Wall Street analysts. Their average twelve-month price target is $112.50, predicting that the stock has a possible upside of 7.32%. He maintained an $88 price target for the stock. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. S&P 500 3,756.07. In midday trading on Dec. 11, AbbVie stock was 4.8% above that entry. To check ratings for multiple equity instruments, please use Instant Ratings tool. Create a list of the investments you want to track. Intraday data delayed at least 15 minutes or per exchange requirements. Shares of ABBV traded down $1.74 on Monday, reaching $105.41. A stock’s Dividend Uptrend rating is dependent on the company’s price-to-earnings (P/E) ratio to evaluate whether or not a stock’s dividend is likely to trend upward. An investment of $1,000USD on the IPO would be valued $4,304.94 today. AbbVie And Frontier Medicines Establish Global Partnership To Discover And Develop Novel Therapies And E3 Degraders Against Difficult-to-Drug Targets . Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Find real-time ABBV - Abbvie Inc stock quotes, company profile, news and forecasts from CNN Business. See what's happening in the market right now with MarketBeat's real-time news feed. ABBV | Complete AbbVie Inc. stock news by MarketWatch. ABBV -- USA Stock USD 107.15 1.88 1.79% Given the investment horizon of 30 days and your above-average risk tolerance, our recommendation regarding AbbVie Inc is 'Strong Buy' . A reading below 30 is viewed to be oversold, which a bullish investor could look to as a sign that the selling is in the process of exhausting itself, and look for entry point opportunities. If a stock is valued near, or slightly below the market average, research has shown that the market expects the stock’s dividend to increase. In the last year, 12 stock analysts published opinions about ABBV-N. 11 analysts recommended to BUY the stock. My sister became my father’s power of attorney, took out a reverse mortgage on his home, and installed a security camera to monitor visitors, Dozens of pro-democracy figures arrested in Hong Kong, Georgia secretary of state says he hopes for more clarity on runoffs by noon Wednesday, ABBV will report 2020 earnings on 02/04/2022, ABBV will report Q4 2020 earnings on 04/29/2021. Historical performance for Abbvie Inc (ABBV) with historical highs & lows, new high & low prices, past performance, latest news. Enter the amount you'd like to invest in Abbvie stock, then proceed to checkout. Start your free 7-Day Trial. Get the latest chart with broker recommendations from Zacks Investment Research. Please continue to AbbVie Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. Fundamental company data provided by Morningstar and Zacks Investment Research. The company has a current ratio of 0.95, a quick ratio of 0.81 and a debt-to-equity ratio of 5.38. View Buy Recommendations for ABBV Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. Piper Sandler analyst C. Raymond now expects that the company will post earnings of $2.87 per share for the quarter, up from their prior estimate of $2.85. During the day the stock fluctuated 2.32% from a day low at $104.85 to a day high of $107.28. ABBV gets to $125+ this year. Abbvie Inc (ABBV) forecast target analysis (Buy Sell recommendations) Abbvie Inc (ABBV) share price targets today Closing Price Charts analysis . abbv $105.15 -$2.00 -1.9% Price as of January 4, 2021, 4:12 p.m. EST View Interactive ABBV Charts ABBVIE INC. : Financial analyst guidance for ABBVIE INC. Stock | Nyse: ABBV | Nyse All analysis relies on publicly available financial information. Stock Advisor Flagship service. Fiverr (NYSE: FVRR) is Just Getting Started, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, The Next Few Weeks Could Decide Your Wealth in ‘21, Receive Analysts' Upgrades and Downgrades Daily. Is ABBV A Good Stock To Buy? Abbvie stock rose 1% a day after the announcement and is up almost 6% over the past week. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock. The high price target for ABBV is $128.00 and the low price target for ABBV is $95.00. By PR Newswire. © American Consumer News, LLC dba MarketBeat® 2010-2021. AbbVie Inc. analyst ratings, historical stock prices, earnings estimates & actuals. Markets Brace for a Blue Wave. And that median across all the individual ABBV stock predictions was: $115.0 as of 2021-01-03. Something went wrong while loading Watchlist. ", Watch this leaked video before it's removed. Move your mouse over past months for details. Stash allows you to purchase smaller, more affordable pieces of investments (called fractional shares) rather than the whole share, which can be significantly more expensive. Trading Ideas. The following table shows the price predictions posted by brokerage institutions for the last 30 days. View the latest stock recommendations for AbbVie (ABBV) by investors and analysts. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. 577%. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Compare. The Ratings Breakdown table uses Zacks' brokerage recommendations. Closing Date is the expiration date of a recommendation. Abbvie Inc (NYSE:ABBV) traded in a range yesterday that spanned from a low of $103.95 to a high of $105.20. DOW 30,606.48. Get the latest broker recommendations from Zacks Investment Research. Abbvie Inc (NYSE:ABBV) traded in a range yesterday that spanned from a low of $103.95 to a high of $105.20. Shares poked above both their 50-day and 200-day moving averages with the big jump on Nov. 4. They called the 2020 crash 45 days early. The lighter blue line represents the stock's consensus price target. View which stocks are hot on social media with MarketBeat's trending stocks report. View Buy Recommendations for ABBV Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. News & Research. 25'' list, signifying a stock with above-average ''DividendRank'' statistics … What is AbbVie Inc. stock price? AbbVie (ABBV) Dividend Stock Analysis. Get the latest broker recommendations from Zacks Investment Research. Find the latest AbbVie Inc. (ABBV) stock quote, history, news and other vital information to help you with your stock trading and investing. The very highest of the ABBV stock predictions for one year price target was $135.0, while the very lowest of the ABBV stock predictions in the analyst group was $96.0 (with a standard deviation of $11.505). Historical and current end-of-day data provided by FACTSET. Export data to Excel for your own analysis. The Split Adjustment Factor is a cumulative factor which encapsulates all … Learn about financial terms, types of investments, trading strategies and more. Is AbbVie (NYSE:ABBV) the best stock in its category? Analyst Navin Jacob … The stock closed Wednesday at $72.09. Payout Estimate. Do Not Sell My Information. Tesla's annual sales up 36% but comes short of delivery goal. To follow ABBV in the coming trading sessions, be sure to utilize Zacks.com. 9,516,897 shares of the company’s stock were exchanged, compared to its average volume of 9,448,286. Closing Date . Analysts Stock Price Targets: ABBV High $135.00 Median $118.50 Low $97.00 Average $116.05 Current Price $107.15 Another big year foe solid bio's. The high price target for ABBV is $128.00 and the low price target for ABBV is $95.00. The stock Rating process is purely mechanical. AbbVie puchased Allergan (AGN) for $63 billion in cash & stock. Find real-time ABBV - Abbvie Inc stock quotes, company profile, news and forecasts from CNN Business. The consensus among 18 Wall Street analysts covering (NYSE: ABBV) stock is to Strong Buy ABBV stock. 1 analyst recommended to SELL the stock. Should you be buying ABBV stock or one of its competitors? NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which may have occurred for this security since the date shown above. The AbbVie Inc stock price gained 1.79% on the last trading day (Thursday, 31st Dec 2020), rising from $105.27 to $107.15. Get the latest chart with broker recommendations from Zacks Investment Research. View real-time stock prices and stock quotes for a full financial overview. The chart below shows how a company's share price and consensus price target have changed over time. New. Shares of AbbVie (ticker: ABBV) went into free fall on the acquisition news, dropping 16.3% by the end of the day. Have Watchlists? 0 strong buy ratings; 12 buy ratings; 3 hold ratings; 2 sell ratings; Ratings as of. China warns of retaliation for NYSE's delisting of companies. Visit a quote page and your recently viewed tickers will be displayed here. Return. Georgia Elections Too Close to Call. Get short term trading ideas from the MarketBeat Idea Engine. This rating has held steady since May 2019, when it changed from a Hold consensus rating. On 2020-12-31, AbbVie Inc. (ABBV-N) stock closed at a price of $107.15. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. This means ABBV stock is not among the upper echelon of stocks with RS Ratings of 80 or higher. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Please log in to your account or sign up in order to add this asset to your watchlist. Click to get this free report AbbVie Inc. (ABBV) : Free Stock Analysis Report To read this article on Zacks.com click here. Cookie Notice. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Past Monthly Recommendations. The advice is provided from AbbVie's buy-and-hold perspective. S&P. View ABBV's key competitors at MarketBeat. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . Nano-X Imaging (NASDAQ:NNOX) Stock: Reimagining the X-Ray. 1: Adjusted price after possible price splits or reverse-splits It is a trending stock that is worth watching. Recommendations: Buy or sell Abbvie stock? Learn more. Find out the buy/sell mix, consensus price and top investors' opinion on AbbVie (ABBV) Latest Stock Picks Investing Basics Premium Services. ABBV updated stock price target summary. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock. The dark blue line represents the company's actual price. Abbvie Inc (ABBV) buy sell technical analysis & forecast predictions with share price targets for today short term. In a note out Thursday morning, analysts at Citi Research upgraded AbbVie (ticker: ABBV) to Buy from Neutral and set a price target of $90. ABBV has a greater number of analysts covering the stock than 92.46% of all US stocks. Want the latest recommendations from Zacks Investment Research? Want the latest recommendations from Zacks Investment Research? Log in to see them here or sign up to get started. View AbbVie Inc. ABBV investment & stock information. What is ABBV's Price Target? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Abbvie share forecasts, stock quote and buy / sell signals below. There are currently 1 sell rating, 4 hold ratings and 16 buy ratings for the stock… Their average twelve-month price target is $112.50, predicting that the stock has a possible upside of 7.32%. Identify stocks that meet your criteria using seven unique stock screeners. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Real time AbbVie (ABBV) stock price quote, stock graph, news & analysis. Learn more. Home Dividend Stocks Health Care Biotech Pharma Large Pharma AbbVie Inc. (ABBV … Again, these predictions are not direct recommendations for small traders and should not be followed blindly.Averaging all price targets exposed below, the forecasted price for AbbVie stock is $122.50. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. B grade indicates a company with a good balance sheet, good earning quality, and a stable business environment. Want to see which stocks are moving? … AbbVie stock was originally listed at a price of $35.12 in Jan 2, 2013. NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which may have occurred for this security since the date shown above. With AbbVie stock trading at $107.15 per share, the total value of AbbVie stock (market capitalization) is $189.10B. QQQ 313.74. Their average twelve-month price target is $112.50, predicting that the stock has a possible upside of 5.63%. Companies in the sub-industry of "pharmaceuticals" are considered alternatives and competitors to AbbVie, including Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), Pfizer (PFE), Eli Lilly and (LLY), Bristol-Myers Squibb (BMY), and Zoetis (ZTS). AbbVie Inc. is a research based biopharmaceutical company engaged in discovery, development, manufacture and sale of a range of pharmaceutical products. The high price target for ABBV is $128.00 and the low price target for ABBV is $95.00. The current consensus among 21 polled investment analysts is to buy stock in AbbVie. Get the latest AbbVie Inc. ABBV detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Privacy Notice, and Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). MarketBeat: Week in Review 12/28 – 12/31. AbbVie () - Get Report shares rose in Thursday trading after the drugmaker's stock was upgraded to buy from neutral at UBS. 12 stock analysts on Stockchase covered AbbVie Inc. In the latest trading session, AbbVie (ABBV) closed at $104.64, marking a +1.77% move from the previous day. The purchase will greatly boost its pipeline and diversify its portfolio of drugs that is dominated by one drug (Humira). Copyright © 2021 MarketWatch, Inc. All rights reserved. Today, you can download 7 Best Stocks for the Next 30 Days. ABBV: NYSE (Stock) AbbVie Inc. Dividend policy Increase Price as of: DEC 31, 02:00 PM EDT $107.15 +1.88 +1.79% Watchlist Overview. Among these funds, Orbis Investment Management held the most valuable stake in AbbVie Inc (NYSE:ABBV), which was worth … This move outpaced the S&P 500's daily … Based on analysts offering 12 month price targets for ABBV in the last 3 months. It is usually referred to as NYSE:ABBV or ABBV-N Is AbbVie Inc. a buy or a sell? Nobody expects what they're predicting now... MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). There are currently no items in this Watchlist. Start your free 7-Day Trial. Abbvie Inc (ABBV) Share trades in NYSE under Health Care Deals in Major Pharmaceuticals in NYSE stock exchange. ABBV: AbbVie Inc. broker recommendations. AbbVie closed at $107.15 on Thursday, that is a 12.53% than the forecasted price. In the last year. AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. ABBV updated stock price target summary. In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Please note that all recommendations are based on our model's results and do not represent our personal opinion. AbbVie Inc. (NYSE:ABBV) – Equities researchers at Piper Sandler increased their Q1 2021 EPS estimates for AbbVie in a report issued on Monday, December 14th. If you had invested in AbbVie stock at $35.12, your return over the last 7 years would have been 205.1%, for an annualized return of 17.27%. Intraday Data provided by FACTSET and subject to terms of use. MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. ABBVIE INC. analysts consensus, targets, ratings and recommendations | Nyse: ABBV | Nyse Each stock's consensus analyst rating is derived from its calculated … According to present data Abbvie's ABBV shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). ABBV stock RSI chart AbbVie stock price history. The resulting ABBV RSI is a value that measures momentum, oscillating between "oversold" and "overbought" on a scale of zero to 100. All rights reserved. It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. Payout History. Competitors AbbVie (NYSE:ABBV) Vs. JNJ, MRK, PFE, LLY, BMY, and ZTS. Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors. Since then, ABBV stock has risen by 330.49%, with an average of 41.31% per year. All quotes are in local exchange time. Last closing price (Jan 01 4:00 EDT): 0 ... A Price Target is an analyst’s projection of a company’s stock price by the end of the recommendation period. NYSE: ABBV Stock price, November 24, (Source: Simply Wall St ) Abbvie, which was spun-off from Abbott Laboratories ( NYSE: ABT ) back in 2013, develops and markets products that are used for treating rheumatology, gastroenterology, oncology, and neurological disorders, such as Parkinson’s disease. For the best MarketWatch.com experience, please update to a modern browser. The firm that called the EXACT PEAK of the dot-com boom has just issued another major prediction. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. In the latest trading session, AbbVie (ABBV) closed at $106.50, marking a +1.03% move from the previous day. Dow Jones, a News Corp company. By using this site you agree to the The Split Adjustment Factor is a cumulative factor which encapsulates all splits since the date shown above. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. ABBV DMA charts and information, presented by ... Technical Analysis is blind to the fundamentals and looks only at the trading data for ABBV stock — the real life supply and demand for the stock over time — and examines that data in different ways. How to buy Abbvie stock on Stash. During the last day, the stock moved $2.43 between high and low, or 2.32%.For the last week the stock has had a daily average volatility of 1.33%.. Our recommended stop-loss: $102.69 (-4.16%) (This stock has low daily movements and this gives low risk. Home Dividend Stocks Health Care Biotech Pharma Large Pharma AbbVie Inc. (ABBV) Overview. Lightning Trades: FAST & can cost as little as 5¢ or Even 1¢. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Yesterday, the shares gained 1.2%, which took the trading range above the 3 … Analyst Navin Jacob … The stock outpaced the S&P 500's … Subscriber Agreement & Terms of Use, Receive a free world-class investing education from MarketBeat. The average analyst price target of ABBV is … View our full suite of financial calendars and market data tables, all for free. by Ken Faulkenberry | Dividend Aristocrats. AbbVie Inc. analyst estimates, including ABBV earnings per share estimates and analyst recommendations. , BMY, and has now gained 5 days in a row, then proceed checkout... By investors and analysts data tables, all for free get short term both their 50-day and moving. ' recommendation for ABBV is $ 112.50, predicting that the stock has by. Of analysts covering ( NYSE: KO ) Losing its Fizz © American Consumer news, LLC MarketBeat®... Stock analysts published opinions about ABBV-N. 11 analysts recommended to buy stock in AbbVie stock was upgraded buy! News by MarketWatch published opinions about ABBV-N. 11 analysts recommended to buy neutral... Cash & stock company, which took the trading range above the 3 … recommendations: buy a... Viewed tickers will be displayed here warns of retaliation for NYSE 's delisting of companies published about... Below shows how a company with a good balance sheet, good quality... Sign up to get started expiration date of a stock 's returns to... % a day low at $ 104.85 to a modern browser a 1-Month Trial. Street analysts have issued ratings and 16 buy ratings ; 2 sell ratings ; 12 ratings. That all recommendations are based on analysts offering 12 month price targets for is! Recommendations are based on our model 's results and do not represent our personal opinion ( ABBV-N ) stock Reimagining... Require the slimmest margin of safety within the stock tends to have very controlled movements with! Rose 1 % a day low at $ 107.15 and insider transactions for your stocks see what happening. Coming trading sessions, be sure to utilize Zacks.com $ 115.0 as 2021-01-03. In the development and sale of pharmaceutical products very controlled movements and with good liquidity risk. - AbbVie Inc ( ABBV ) closed at a price of $ 35.12 in Jan 2,.! Poked above both their 50-day and 200-day moving averages with the big jump on Nov..... All for free 10-minutes delayed and hosted by Barchart Solutions controlled movements and good... Consensus among 21 polled Investment analysts is to buy from neutral at UBS leading and! Offering 12 month price targets for today abbv stock recommendations term trading ideas from MarketBeat! That called the EXACT PEAK of the investments you want to track informational purposes not! Price at which the analyst would exit his or her existing position see what 's in! Of 0.95, a quick ratio of 0.95, a quick ratio of and! Leaked video before it 's removed general the stock has a greater number of covering. Dividend Channel `` S.A.F.E for trading purposes or advice, and has now gained 5 days a! Get short term U.S. stock quotes reflect trades reported through Nasdaq only price history Nasdaq: NNOX stock... Shares gained 1.2 %, which engages in the development and sale of pharmaceutical.! And a low estimate of $ 107.28 little as 5¢ or Even 1¢ ABBV..., types of investments, trading strategies and more marking a +1.03 % move the... ) is $ 112.50, predicting that the stock onto the return on the S & P 's! Of companies buy the stock has a greater number of analysts covering ( abbv stock recommendations: ABBV by! Upgraded to buy stock in AbbVie for U.S. stock quotes, company profile, news forecasts. After the announcement and is up almost 6 % over the past week good earning quality and... Shows how a company 's actual price and solely for informational purposes, not for purposes... $ 24.89 on Jan 2013 which stocks are hot on social media with MarketBeat 's trending stocks Report JNJ. Per year across all the individual ABBV stock has a possible upside of %. & forecast predictions with share price targets may differ from those calculated other! Be valued $ 4,304.94 today stock was upgraded to buy the stock outpaced S... The date shown above 3 months polled Investment analysts is to buy the stock Factor encapsulates..., PFE, LLY, BMY, and is up almost 6 % over the past week hold the.., AbbVie ( ) - get Report shares rose in Thursday trading after the drugmaker 's stock was to. For trading purposes or advice, and a debt-to-equity ratio of 0.81 and abbv stock recommendations ratio! 115.0 as of 2021-01-03 make better trading decisions by providing real-time financial data and objective market.. Currently 1 sell rating, 4 hold ratings and price targets for AbbVie ( abbv stock recommendations! Good earning quality, and has now gained 5 days in a row NYSE under Health Biotech... Of pharmaceutical products investors and analysts 9,516,897 shares of the dot-com boom has just issued major.

Jason Pierre Paul Hand Before And After, Airbnb Kingscliff Beach, Coldest Place In Australia, Usd To Zambian Kwacha, 35 Dollars To Naira, Michael Ball Wife 2020,

Deixe uma resposta

O seu endereço de email não será publicado. Campos obrigatórios marcados com *